An invasive strain-specific monoclonal antibody against Entamoeba histolytica has been used in a capture enzyme-linked immunosorbent assay (ELISA) for the detection of invasive E. histolytica fecal antigen in clinical specimens and for the diagnosis of amebic dysentery in patients from Bangladesh. The fecal antigen capture ELISA (FAC-ELISA) did not cross-react with other parasite species in the clinical specimens or with noninvasive E. histolytica present in those specimens and in experimentally seeded stools. The limit of detection of the assay for invasive E. histolytica crude antigen diluted in phosphate-buffered saline or in stools was 0.58 and 3.9 ,ug/ml, respectively, which is the equivalent of approximately 72 and 487 E. histolytica trophozoites per well, respectively. The sensitivity, specificity, and eficiency of the FAC-ELISA were 87, 100, and 98%, respectively, for the detection of invasive E. histolytica antigens and 100, 100, and 100%, respectively, for the diagnosis of amebic dysentery. The FAC-ELISA is a potential alternative for the field diagnosis of amebic dysentery and for epidemiological studies to define the distribution of invasive E. histolytica.
The protozoan parasite Entamoeba histolytica is the etiological agent of human amebiasis. Approximately 500 million people are infected worldwide with E. histolytica, but only 10% develop invasive amebiasis (38) . Like other diarrheal diseases, amebiasis is more prevalent in developing countries and produces between 40,000 and 100,000 deaths per year (40) . The discrepancy between the number of carriers and the relatively low percentage of patients developing invasive amebiasis could in part be explained by higher prevalence of infection with noninvasive strains of the parasite, which are morphologically indistinguishable but genotypically distinct from invasive strains (3, 4, 6) . Failure to identify nonpathogenic amebae such as Entamoeba coli and Entamoeba hartmanni may also increase the apparent prevalence of asymptomatic E. histolytica infection (17, 22, 29) .
Microscopical examination of stools does not differentiate between invasive and noninvasive strains of E. histolytica, is time-consuming, and requires a skillful microscopist for the detection and recognition of E. histolytica trophozoites with ingested erythrocytes (22, 38) . Differential diagnosis of amebic dysentery (AD) at present requires facilities for isolating bacterial agents such as Shigella spp., Salmonella spp., Campy-lobacter spp., or Yersinia spp. or for the recognition of clinical conditions such as rectal infection by Chlamydia trachomatis, Treponema pallidum, and Neisseria gonorrhoeae (19) . AD must also be differentiated from idiopathic intestinal inflammatory diseases, namely, Crohn's disease and ulcerative colitis (28) .
The development of fecal antigen detection assays has been designated a priority in amebiasis research by the World Health Organization (40) : such assays detect only current infections and can be very useful in epidemiological studies. The adaptation of an invasive strain-specific monoclonal antibody (MAb) to a fecal antigen capture enzyme-linked immunosorbent assay (FAC-ELISA) would enhance the diagnosis of intestinal amebiasis and differentiate that diagnosis from other intestinal infections such as bacillary dysentery in carriers of noninvasive E. histolytica.
We have produced an invasive strain-specific MAb (20/7D) against E. histolytica which has been used in an indirect immunofluorescence test to characterize E. histolytica isolates from several geographical regions (15 (20); at Universidad de los Andes (UNIANDES), thin-layer starch gel electrophoresis was used according to the methods of Sargeaunt and Williams (25) Isoenzyme profiles were visualized with an agar overlay (10, 27) .
FAC-ELISA. Three sample sets were assayed for E. histolytica antigen. Two were experimentally seeded (spiked) with either E. histolytica NP-40 extract (at London School of Hygiene and Tropical Medicine [LSHTM]) or with intact polyxenic E. histolytica trophozoites (at ICDDR,B), and one set consisted of clinical stool samples from patients in Bangladesh. Spiked samples were prepared as follows: E. histolytica NP-40 extract from several isolates was diluted at 50 ,ug/ml in PBS and stored at -20°C. E. histolytica isolates were harvested (200 ill, at ICDDR,B) from 2-day-old biphasic Robinson's cultures yielding -2 x 103 trophozoites (24), mixed with 0.5 ml of parasite-free feces (final protein, -2.3 ,ug/ml), frozen, and kept at -20°C until assayed at LSHTM. Estimates of the FAC-ELISA detection limit were made with twofold serial dilutions of E. histolytica NIH:200 NP-40 extract in PBS and parasite-free stools at a starting concentration of 50 ,ug/ml.
Aliquots of dilutions (100 [lI) were assayed by FAC-ELISA (below). To estimate the number of trophozoites per 100 RI, it was assumed that 106 were equivalent to -0.8 mg of E. histolytica protein (8) .
Clinical stool samples collected and examined at ICDDR,B
were kept at -20°C and transported frozen to the LSHTM, where they were mixed 1:3 with fecal diluent (PBS-0.02% sion three times in liquid N2 and by centrifugation at 8,500 x g fdt 30 min and stored at -20°C until assayed blindly at LSHTM. Alternate rows of flat-bottomed polystyrene microplates (Immulon II; Dynatech Laboratories Ltd., Billingshurst, Sussex, United Kingdom) were coated overnight at 40C, either with affinity-purified polyclonal rabbit antisera raised against E. histolytica trophozoites or with nonimmune rabbit immunoglobulin G (Jackson Immunoresearch Inc., Philadelphia, Pa.), at 1 ,ug of protein per well in coating buffer (7.5 mM Na2CO3-17.4 mM NaHCO3-0.02% NaN3, pH 9.6). All subsequent washes were with PBS-0.05% Tween 20. Working dilutions of reagents were determined by checkerboard titration. After three washings, plates were blocked (coating buffer-2% casein) for 1 h at 37°C and again washed three times, and 100 ,ul of fetal calf serum was dispensed into all wells, followed by either 100 p.l of spiked PBS-parasite-free stools or 100 ,ul of fecal supernatant dispensed into immune and nonimmune rabbit immunoglobulin G-coated wells. After incubation for 2 h at room temperature, plates were washed five times and 100 ,ul of a 1/1,500 dilution of mouse ascites containing invasive strain-specific MAb 20/7D (15) (Table 2) .
Detection limit of the E. histolytica FAC-ELISA. The detection limit of the E. histolytica FAC-ELISA was estimated by assaying serial dilutions of E. histolytica protein in PBS and parasite-free stools. The ELISA could detect 0.58 jig of E.
histolytica protein per ml in PBS (Fig. 1 ) and 3.9 ,ug/ml in parasite-free stools, equivalent to approximately 72 and 487 E. histolytica trophozoites, respectively, per well (100 ,ul). (Table 3) , and 28 had no parasitic infection. There were no significant differences in age and sex distribution of patients with and without parasitic infections (not shown). Among other parasitic protozoa found by microscopy, the most common were the commensal flagellate Pentatrichomonas hominis and Blastocystis hominis, which is associated with DIA (1). Ascaris lumbricoides and Trichuris trichiura, both recognized pathogens (2), were the most common helminths. A total of 15 of the E. histolytica samples contained invasive strains, and 32 contained noninvasive strains according to zymodeme analysis of cultured isolates. The FAC-ELISA detected E. histolytica antigen in 13 of 15 samples containing invasive E. histolytica and none of 93 samples from the other three groups (Fig. 2A) . Sensitivity and specificity were accordingly 87 and 100%, respectively. The FAC-ELISA was secondly tested with stool samples classified by diagnosis of diarrheal disease (14a). In this case, stool samples were separated into four groups: AD (9 samples), dysentery of unknown etiology (18 samples), DIA (68 samples), and asymptomatic carriers (AC) (7 samples). Samples in the DIA (five samples) and AC (one sample) groups which were included in the first test and known to be from patients infected with invasive E. histolytica were excluded from this analysis (see Discussion). The FAC-ELISA detected all AD cases but was negative with dysentery of unknown etiology cases and the remaining 77 samples in the a ODs from wells coated with nonimmune rabbit antisera were subtracted from ODs obtained with wells coated with rabbit antisera against E. histolytica, resulting in negative values in some categories.
b Corresponding unpaired t test against invasive E. histolytica infection or AD.
DIA and AC groups (Fig. 2B) . Accordingly, sensitivity and specificity for AD were both 100% in this second test. The differences between the means of the ODs obtained in the assay from the two assessments were statistically significant (Table 4) . On the basis of the observed prevalence of invasive E. histolytica infection (15 cases of 108 individuals; 14%), the positive and negative predictive values of the FAC-ELISA were 100 and 98%, respectively ( 13 and 1 of 4, respectively) . It is evident that there is some degree of antigen degradation during sample processing. False negatives could also result from antigenic variation between invasive E. histolytica strains, although this is unlikely as MAb 20/7D has recognized isolates from at least three diverse regions of endemicity (15) .
The limit of detection of the FAC-ELISA was lower with stools than with PBS (Fig. 1) . This may be due to background in stools which decreases as stools are diluted (Fig. 1) or by stool interference with the FAC-ELISA. Part of this interference may be the proteolytic activity of feces, which are known to degrade antibodies (35) . Although fixation of stool samples with formalin has increased the performance of antigen detection tests for Giardia intestinalis (14, 31) , previous antigen detection assays for E. histolytica have produced unsatisfactory results with formalinized stool samples (21, 33) .
The detection limit of this FAC-ELISA is similar to that of other E. histolytica antigen detection assays, and detection limit in stools even as low as 2.3 p.g of soluble E. histolytica protein per ml could be below levels of microscopical detection. Detection of Giardia intestinalis antigen in the absence of microscopically detectable organisms in feces is possible several days after treatment (18) .
The cutoff value of the FAC-ELISA was calculated with the OD from all nonimmune wells in the microplate. This avoids the need for a group of parasitologically negative stools which may be difficult to obtain in regions of endemicity.
As a crucial part of our study, we wanted to compare the performance of the FAC-ELISA with a clearly defined group of AD cases and other groups of stool samples without invasive E. histolytica. So, six cases of known invasive E. histolytica infection which did not fulfill the criteria for being classified as dysentery were excluded from the analysis of the FAC-ELISA against diagnosis of diarrheal disease (five in the DIA group and one in the AC group; see Materials and Methods). Should those cases not have been excluded, invasive E. histolytica culture-positive stools in diagnostic categories other than AD would have been labelled as false positives or false negatives. Furthermore, all the cases with invasive E. histolytica infection, regardless of diagnosis, were pooled in one group, and the results obtained were compared with groups of samples containing noninvasive E. histolytica, other parasites, and no parasitic infection. Those results showed that with some nondysenteric stools the FAC-ELISA gave false negatives but maintained a high specificity for invasive E. histolytica.
In conclusion, the FAC-ELISA is a potential alternative to the microscopical diagnosis of AD, although further assay development is required. This assay is more practical than culture and zymodeme analysis. This rapid FAC-ELISA could improve clinical management of dysentery as the result is available on the same day and for ulcerative colitis and Crohn's disease (28) (5) . An important epidemiological application could be the clarification of the distribution of invasive E. histolytica, with the possibility of targeting antiamebic treatment to areas of high endemicity or carriers of invasive strains (40) , such as professional food handlers, and household contacts of index cases of invasive amebiasis.
